Sign In

Keynote Speakers

Home \ Annual Conference

HCP Conference 2018 – Speakers Bio

llspeaker-drandrew.png

Hypertension

Dr. Andrew Don-Wauchope – Vice President Clinical Services, LifeLabs and Professor Pathology and Molecular Medicine, McMaster University.

Description: Blood pressure evaluation in assessing hypertension

Presenter Bio: Dr. Don-Wauchope is a Laboratory Physician practising as a Medical Biochemist with LifeLabs and he still maintains a small clinical practice as an Endocrinologist. This practice is at the Hamilton General Hospital where he sees patients with Lipid disorders.

He obtained his medical degree from the University of Witwatersrand in South Africa and followed this with a period of work as general practitioner. Subsequently he specialised in internal medicine, followed by a post-doctoral research fellowship in Edinburgh and then further training in Chemical Pathology in Edinburgh, Scotland. He has work experience from Dublin, Ireland and Hamilton, Ontario prior to joining LifeLabs in June 2016.

From the LifeLabs Clinical Laboratory perspective he has an interest in measurement of all items related to the endocrine system. Specifically he has responsibility for a single area within the laboratory but able supports his colleagues for clinical chemistry across both Ontario and B.C. He has represented the Clinical Laboratory community on an Endocrine Society Clinical Practice Guideline and the Canadian Hypertension Guideline and has both an academic and practical interest in the production, evaluation and implementation of evidence based laboratory medicine guidelines.

His major role with LifeLabs is as the leader for the Medical Scientific group on a national basis. In this role he is involved in a number of different activities where he represents both the interests of the Clinical Laboratory professionals working with LifeLabs as well as the interest of LifeLabs.

He holds a university appointment as Professor with Pathology and Molecular Medicine at McMaster University with an associate appointment in Internal Medicine (Division of Endocrinology). He is on the American Association Clinical Chemistry Core Education Committee. He has a research interest in laboratory utilisation and has published more than 50 peer reviewed papers.

llspeaker-drandrew.png

Choosing Wisely – making the most of health care dollars

Dr. William Schreiber – Clinical Director Chemistry BC, LifeLabs Professor, Dept. of Pathology and Laboratory Medicine, UBC

Description: In April 2012, the American Board of Internal Medicine Foundation, along with Consumer Reports, formally launched the Choosing Wisely campaign with the release of “Top Five” lists from nine specialty societies. Today, more than 70 societies comprising over one million clinicians are now partners of the Choosing Wisely campaign.

This presentation will briefly review the background and principles behind Choosing Wisely. Several recommendations pertinent to test ordering will be highlighted.

Presenter Bio: Dr. William E. Schreiber is the Clinical Director for Chemistry, BC. In this role, he provides medical oversight for all chemistry testing in British Columbia. Prior to joining LifeLabs, he worked in the Division of Clinical Chemistry at Vancouver General Hospital. He also served as medical director of the Provincial Toxicology Center, which provides both forensic and clinical toxicology services for the entire province.

Since joining the faculty at UBC, he has committed a large part of his career to the education of medical students, residents and colleagues. He directed the medical biochemistry residency program for 10 years and served as associate dean for undergraduate education at UBC from 1999-2002. He has received a number of teaching awards from students and peers, as well as recognition from professional organizations for contributions to continuing medical education.

Dr. Schreiber has been active in professional organizations in the US and Canada. In 2016, he became president of the American Society for Clinical Pathology (ASCP), the largest pathology organization in North America. He served on the editorial board of Lab Tests Online (labtestsonline.org) and continues to review for the American Journal of Clinical Pathology. His research interests are eclectic, with more than 60 publications in peer-reviewed journals.

dr-christinelee.png

Current Challenges in Management of C. Difficile Infection (CDI)

Dr. Christine Lee – Medical Microbiologist, Island; Professor and Infectious Diseases Physician and Professor Pathology and Molecular Medicine

Description: Cased-based management of primary and recurrent CDI

Presenter Bio: Dr. Christine Lee obtained a medical degree from the University of Toronto, and completed her residency in infectious diseases and medical microbiology at the University of Toronto. Currently, Dr. Christine Lee is a professor at the department of pathology and molecular medicine at McMaster University and a clinical professor at the University of British Columbia. She has been performing FMT for recurrent C.Difficile Infection (CID) and active ulcerative colitis since 2008.

dawnsiciliano.png

Incorporating Genetics into Clinical Care

Dawn Siciliano, MSc, CCGC - Genetic Counsellor at LifeLabs Genetics, Clinical Instructor, UBC

Description: Rapid advances in genetics are revolutionizing personalized medicine and changing the face of primary care. To better understand how genetics can be incorporated into every day clinical practice, this presentation will provide an overview of various genetic technologies, specifically offered through LifeLabs Genetics, through a rolling case study that could be encountered in primary care. Testing discussed will focus on pre-conception and prenatal screening, hereditary disease and pharmacogenetics.

Presenter Bio: Dawn Siciliano is a Canadian Certified Genetic Counsellor who joined LifeLabs Genetics in late August 2017. She is an integral part of the clinical team involved in service development and delivery of LifeLabs Genetics full suite of genetic testing products, as well as counselling, education and training.

She graduated from the University of Manitoba with a BSc, Honours in Genetics. She continued her studies completing an MSc in Genetic Counselling at the University of British Columbia. Her career started in private industry working as a Clinical Genetics Specialist at Xenon Genetics. She then moved into clinical care at the Provincial Medical Genetics Program at BC Children's and Women's Hospital, where she provided genetic counselling in prenatal, pediatric and adult genetics for 13 years. She continued on further refining her counselling skills as a Clinical Counsellor at BC Women's Health Centre, where she counselled women on reproductive health issues. She is a Clinical Instructor at the University of British Columbia and regularly teaches and supervises medical students and genetic counselling students.

dawnsiciliano.png

Thalassemia/Hemoglobinopathies: A Glimpse into LifeLabs’ experience & new policies - to avoid unnecessary duplicate testing

Dr. Anil Mangal - Clinical Director Hematology BC, LifeLabs; Clinical Associate Professor, Department of Pathology & Laboratory Medicine, UBC

Description:

Hemoglobinopathy/ thalassemia investigation (EHG) at LifeLabs, is centralized at Burnaby Regional Laboratory (BRL). These tests are performed on out-patients referred from various communities thru-out BC.

Prior to the integration of the two major outpatient community laboratories in BC (BC Biomedical & LifeLabs Medical Laboratories), a retrospective analysis of 2015 data showed these laboratories, had tested 10,939 patients for EHGs during the year.

In addition to Iron deficiency, repeat EHG testing was also noted in our study which led to LifeLabs changing its workflow and implemented new policies since integration, where repeat requests for EHG are cancelled and NO unnecessary repeat EHG testing is done.

EHG is a useful investigation for unexplained/ persistent anemia or abnormal RBC morphologic findings. EHG cannot be interpreted in isolation: hematologic parameters, Iron status, ethnic background and relevant diagnosis, must all be provided. Ferritin/ Iron studies are needed in all patients before EHG testing.

Unnecessary duplicate EHG testing can be avoided, as already implemented at LifeLabs Medical Laboratories, with significant LifeLabs resource utilization but cost savings.

Presenter Bio:
Dr. Mangal is a Laboratory Physician, practicing as Hematopathologist with LifeLabs BC. His primary role with LifeLabs is Medical Team Lead for Hematology Discipline, LifeLabs BC.

He holds a university faculty appointment with Department of Pathology & Laboratory Medicine, University of British Columbia. Dr. Mangal is actively involved with UBC Hematopathology Resident Training Program. He is the Onsite Coordinator for UBC Hematopathology Residents, at LifeLabs BC.

Dr. Mangal has authored ten peer-reviewed publications and numerous abstracts/ papers during his 35 years of career as a Hematopathologist. One of his publications “Acquired hemolytic anemia due to auto Anti-A or auto Anti-B induced by group O homograft in renal transplant recipients” Transfusion, 1984; 24 (3):201-5; has been cited/Referenced 59 times as of Nov. 2011. In 2008, Dr. Mangal was recognized for his “Long-term Contribution: 25 completed years” at UBC Faculty of Medicine, Dept. of Pathology and Laboratory Medicine.

Dr. Mangal also holds “Masters of Business Administration (MBA)” from University of Simon Fraser, BC.

Did you know that you can book your appointment online?

Book an Appointment